Jubilant Organosys Ltd, headquarted at Noida, near New Delhi, announced that its subsidiary Jubilant Biosys Ltd based in Bangalore has developed a next generation screening solution, Legend NGSS, that will further enable the process of high throughput screening, accelerating global drug discovery. The software to be launched in the US and Europe initially, allows scientists to capture, store, and analyze Oracle 9i/10g based screening data with greater flexibility, accuracy and speed.
The details can be read here.
No comments:
Post a Comment